U.S. federal trademark · Serial No. 86839247 · Reg. No. 5174212
Providing personalized healthcare and medical information, namely, providing medical information and reports that will enable doctors and clinicians to select and recommend the appropriate treatment for patients through the use of data obtained through personalized pharmacogenetics, proteomics and other biological testing, individual behaviors including medication compliance, exercise diet, sleep patterns and language, epigenetic and environmental factors, and bioinformatics analysis, and consultation services related thereto; medical testing services for diagnostic and treatment purposes, namely, providing medical tests that measure, analyze and interpret genes of patients, environmental, and other factors to predict which drugs and/or treatment programs have the best opportunity for positive outcomes for patients, personalize medication selection and treatment options and choices for patients, identify potentially harmful drug interactions and calculate drug dosage adjustments for patients, and providing medical information to patients and medical professionals in the form of reports for the foregoing medical testing services; medical analysis and consultation services which use bioinformatics for diagnostic or treatment purposes; gene and tissue bank services that provide DNA samples for use in future medical and scientific research, medical and scientific educational studies and development of new medical and scientific products and validation thereof
Scientific research analysis and consulting services which use bioinformatics
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.